Are female bipolar patients of reproductive age aware of the teratogenic risk of sodium valproate? A qualitative study
- PMID: 35169512
- PMCID: PMC8831931
- DOI: 10.4102/sajpsychiatry.v28i0.1719
Are female bipolar patients of reproductive age aware of the teratogenic risk of sodium valproate? A qualitative study
Abstract
Background: Sodium valproate is considered the most teratogenic of all anticonvulsant drugs. Internationally, new regulations require women to sign risk assessment forms if initiated on it.
Aim: This study aimed to explore patients' awareness of the teratogenic risk of sodium valproate.
Setting: Weskoppies Psychiatric Hospital, Tshwane, Gauteng.
Methods: We conducted a qualitative study comprising 23 semi-structured interviews with female bipolar patients of reproductive age at a tertiary psychiatric hospital in South Africa.
Results: Patient psychoeducation and self-education is improving as many patients were aware of the risk of teratogenicity of sodium valproate either by being educated or by searching online after developing an interest. Our study identified the need for female patients to be educated about contraceptive use when starting on sodium valproate to avoid pregnancy.
Conclusion: Our study shows that patients are becoming more aware of the teratogenic risk of sodium valproate. This suggests that consultations focusing on the issues of conception and the use of sodium valproate in women of childbearing potential has improved.
Keywords: 18–44 year olds; bipolar disorder; childbearing age; sodium valproate (epilim); teratogenicity.
© 2022. The Authors.
Conflict of interest statement
The authors declare that they have no financial or personal relationships that may have inappropriately influenced them in writing this article.
Similar articles
-
The valproate prescription pattern for female mental healthcare users of reproductive age.S Afr J Psychiatr. 2024 Mar 26;30:2158. doi: 10.4102/sajpsychiatry.v30i0.2158. eCollection 2024. S Afr J Psychiatr. 2024. PMID: 38628904 Free PMC article.
-
Measures to Mitigate Sodium Valproate Use in Pregnant Women With Epilepsy.Cureus. 2022 Oct 10;14(10):e30144. doi: 10.7759/cureus.30144. eCollection 2022 Oct. Cureus. 2022. PMID: 36381886 Free PMC article. Review.
-
Patterns in Psychiatrists' Prescription of Valproate for Female Patients of Childbearing Age With Bipolar Disorder in Japan: A Questionnaire Survey.Front Psychiatry. 2020 Apr 15;11:250. doi: 10.3389/fpsyt.2020.00250. eCollection 2020. Front Psychiatry. 2020. PMID: 32351410 Free PMC article.
-
Teratogenic medications and concurrent contraceptive use in women of childbearing ability with epilepsy.Epilepsy Behav. 2015 Nov;52(Pt A):212-7. doi: 10.1016/j.yebeh.2015.08.004. Epub 2015 Nov 6. Epilepsy Behav. 2015. PMID: 26460786
-
Sodium valproate in pregnancy: what are the risks and should we use a shared decision-making approach?BMC Pregnancy Childbirth. 2018 Jun 1;18(1):200. doi: 10.1186/s12884-018-1842-x. BMC Pregnancy Childbirth. 2018. PMID: 29859057 Free PMC article. Review.
Cited by
-
The valproate prescription pattern for female mental healthcare users of reproductive age.S Afr J Psychiatr. 2024 Mar 26;30:2158. doi: 10.4102/sajpsychiatry.v30i0.2158. eCollection 2024. S Afr J Psychiatr. 2024. PMID: 38628904 Free PMC article.
-
Measures to Mitigate Sodium Valproate Use in Pregnant Women With Epilepsy.Cureus. 2022 Oct 10;14(10):e30144. doi: 10.7759/cureus.30144. eCollection 2022 Oct. Cureus. 2022. PMID: 36381886 Free PMC article. Review.
-
Sexual and reproductive health needs of women with severe mental illness in low- and middle-income countries: A scoping review.PLoS One. 2025 Jan 16;20(1):e0311554. doi: 10.1371/journal.pone.0311554. eCollection 2025. PLoS One. 2025. PMID: 39820210 Free PMC article.
References
-
- American Psychiatric Association . Diagnostic and statistical manual of mental disorders: Dsm-5. 5th ed. Washington, DC: American Psychiatric Association; 2013.
LinkOut - more resources
Full Text Sources